Federal judge rejects expansion of association health plans

A federal judge rejected the Trump administration’s efforts to expand access to association health plans March 29, throwing small businesses that rely on those plans into a state of uncertainty, the Washington Post reported.

U.S. District Judge John D. Bates said association health plans, which allow small business owners and sole proprietors to band together and buy insurance at discounted rates, were “clearly an end-run” around Affordable Care Act provisions and violated the ACA. Association health plans have only been in play for around six months, but companies who did take action in that time are unsure of what their insurance situation will look like if those plans become insolvent.

In the past, policyholders have been stuck with medical bills in these cases, according to the Post. The U.S. Government Accountability Office reported that between 2000 and 2002 there were 144 plans that weren’t authorized to sell health insurance but did, resulting in more than $250 million in unpaid medical claims.

Bates backed his ruling with the comment that sole proprietors of eligible businesses could be counted as both employees and employers under association health plans, which negates established definitions under the Employee Retirement Income Security Act of 1974.

Read the full story below:

""

After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.